Stockwell 1992.

Methods	Randomised controlled trial. No information given on method of randomisation No loss to follow‐up Blinding not mentioned
Participants	475 patients admitted to the ICU. Patients were excluded from the study if they were < 18 years or if admitted for cardiac monitoring or cardiac thrombolytic therapy
Interventions	1) 4.5% Albumin (n = 226) 2) Synthetic colloid polygeline (Haemaccel) (n = 249) for IV volume replacement
Outcomes	Death Length of stay in ICU Incidence of renal failure Pulmonary oedema
Notes	Follow‐up until discharge from ICU
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	Unclear. No information given on allocation